RecruitingNot ApplicableNCT07219082

Behavioral Safety and Fentanyl Education: BSAFE

Sponsor

San Francisco Department of Public Health

Enrollment

160 participants

Start Date

Aug 11, 2026

Study Type

INTERVENTIONAL

Conditions

Drug Overdose Drug Overdose Accidental

Summary

BSAFE is a randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among people who use stimulants who may have unintentional fentanyl use (UFU). It includes an established overdose education curriculum within an Informational-Motivation-Behavior (IMB) model. This study will test the efficacy of BSAFE vs attention-control.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Attention control and a behavioral approach called BSAFE Intervention for people with drug overdose and drug overdose accidental. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALBSAFE Intervention

The intervention will include counseling sessions, reminder safety text messages, and linkage to care.

BEHAVIORALAttention control

Attention control (videos)

Locations(1)

San Francisco Department of Public Health

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07219082

Related Trials

Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning

NCT071930691 location

CytOSorb TreatMent Of Critically Ill PatientS Registry

NCT0514633628 locations